Zoledronic acid dominant option for Paget's disease

By  

Inpharma, Vol. 1, Iss. 1566, 2006-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Effectiveness and safety of eribulin mesylate: a new therapeutic option in the treatment of metastatic breast cancer

By O'Sullivan Coyne Geraldine   Walsh Janice   Kelly Catherine M  

Expert Opinion on Drug Safety, Vol. 11, Iss. 4, 2012-07 ,pp. : 643-650

Informa Healthcare

Access to resources Recommend Favorite

Letrozole is an effective option in the treatment of early-stage or advanced breast cancer in postmenopausal women

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 21, Iss. 1, 2005-01 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite

Bevacizumab: a potential new option in the treatment of advanced breast or non-small-cell lung cancer

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 22, Iss. 9, 2006-09 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite

Is mastectomy undertreatment for low-risk breast cancers eligible for breast-conserving therapy?

By  

Cancer, Vol. 121, Iss. 16, 2015-08 ,pp. : 2705-2712

Blackwell Publishing

Access to resources Recommend Favorite